e-learning
resources
Virtual 2020
Pre-Congress Content
Localised non-small cell lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Accuracy of pre-operative staging of non-small cell lung cancer in the West of Scotland
A. Alkarn (Glasgow, United Kingdom), J. Van Der Horst (Glasgow, United Kingdom), J. Maclay (Glasgow, United Kingdom)
Source:
Virtual Congress 2020 – Localised non-small cell lung cancer
Session:
Localised non-small cell lung cancer
Session type:
E-poster session
Number:
1633
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Alkarn (Glasgow, United Kingdom), J. Van Der Horst (Glasgow, United Kingdom), J. Maclay (Glasgow, United Kingdom). Accuracy of pre-operative staging of non-small cell lung cancer in the West of Scotland. 1633
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004
Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009
Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006
Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 784s
Year: 2006
Surveillance imaging and recurrence rates following surgery for non-small cell lung cancer (NSCLC).
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Advanced non-small cell lung cancer (NSCLC): observation of chemotherapy in 5 European countries
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
Source: Breathe, 14 (4) 342; 10.1183/20734735.027118
Year: 2018
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008
Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007
N-staging in CT N
0
-N
1
non-small cell lung cancer patients: is there any place for mediastinoscopy?
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007
Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Diagnostic value of EBUS in staging of nonsmall cell lung carcinoma
Source: Annual Congress 2008 - Endoscopic needle techniques
Year: 2008
Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Age and stage at presentation in lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept